A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma
Authors
Keywords
-
Journal
CANCER
Volume 119, Issue 1, Pages 72-80
Publisher
Wiley
Online
2012-06-27
DOI
10.1002/cncr.27696
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study
- (2011) C B Lajer et al. BRITISH JOURNAL OF CANCER
- Clinical Significance of miR-146a in Gastric Cancer Cases
- (2011) R. Kogo et al. CLINICAL CANCER RESEARCH
- Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma
- (2011) Chung-Ji Liu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status
- (2010) James S. Lewis et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma
- (2010) C.-J. Liu et al. CANCER RESEARCH
- A MicroRNA Expression Signature for Cervical Cancer Prognosis
- (2010) X. Hu et al. CANCER RESEARCH
- miR-146a Suppresses Invasion of Pancreatic Cancer Cells
- (2010) Y. Li et al. CANCER RESEARCH
- Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas
- (2010) A. B.Y. Hui et al. CLINICAL CANCER RESEARCH
- MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma
- (2010) Xiqiang Liu et al. FEBS LETTERS
- Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus
- (2010) Abigail I. Wald et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma
- (2009) Geoffrey Childs et al. AMERICAN JOURNAL OF PATHOLOGY
- Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis
- (2009) Douglas R. Hurst et al. CANCER RESEARCH
- MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
- (2009) M. Avissar et al. CLINICAL CANCER RESEARCH
- Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma
- (2009) Wei Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection
- (2009) Gypsyamber D’Souza et al. JOURNAL OF INFECTIOUS DISEASES
- A PCR-based platform for microRNA expression profiling studies
- (2009) X. Wang RNA
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
- (2008) Sung-Liang Yu et al. CANCER CELL
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
- Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
- (2008) Maura L. Gillison et al. JNCI-Journal of the National Cancer Institute
- Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
- (2008) K. Jazdzewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More